Symptom Dimensions in Obsessive-Compulsive Disorder as Predictors of Neurobiology and Treatment Response
- 102 Downloads
Purpose of review
Specific symptom dimensions of obsessive-compulsive disorder (OCD) have been suggested as an approach to reduce the heterogeneity of obsessive-compulsive disorder, predict treatment outcome, and relate to brain structure and function. Here, we review studies addressing these issues.
The contamination and symmetry/ordering dimensions have not been reliably associated with treatment outcome. Some studies found that greater severity of sexual/aggressive/religious symptoms predicted a worse outcome after cognitive behavioral therapy (CBT) and a better outcome after serotonin reuptake inhibitors (SRIs). Contamination symptoms have been related to increased amygdala and insula activation in a few studies, while sexual/aggressive/religious symptoms have also been related to more pronounced alterations in the function and structure of the amygdala. Increased pre-treatment limbic responsiveness has been related to better outcomes of CBT, but most imaging studies show that important limitations and replication in large-scale studies is needed. We review possible reasons for the strong limbic involvement of the amygdala in patients with more sexual/aggressive/religious symptoms, in relation to their sensitivity to CBT.
Symptom dimensions may predict treatment outcome, and patients with sexual/religious/aggressive symptoms are at a greater risk of not starting or delaying treatment. This is likely partly due to more shame and perceived immorality which is also related to stronger amygdala response. Competently delivered CBT is likely to help these patients improve to the same degree as patients with other symptoms.
KeywordsSymptom dimension Treatment outcome Brain function Brain structure
Compliance with ethical standards
Conflict of interest
Anders Lillevik Thorsen declares that he has no conflict of interest. Gerd Kvale declares that she has no conflict of interest. Bjarne Hansen declares that he has no conflict of interest. Odile A. van den Heuvel declares that she has no conflict of interest.
Human and animal rights and informed consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 2.Huppert JD, Simpson HB, Nissenson KJ, Liebowitz MR, Foa EB. Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls. Depress Anxiety. 2009;26(1):39–45. https://doi.org/10.1002/da.20506.CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Mathers C, Fat DM, Boerma JT. The global burden of disease: 2004 update. World Health Organization; 2008.Google Scholar
- 5.Skapinakis P, Caldwell DM, Hollingworth W, Bryden P, Fineberg NA, Salkovskis P, et al. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2016;3(8):730–9. https://doi.org/10.1016/S2215-0366(16)30069-4.CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Hasler G, Pinto A, Greenberg BD, Samuels J, Fyer AJ, Pauls D, et al. Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD collaborative genetics study. Biol Psychiatry. 2007;61(5):617–25. https://doi.org/10.1016/j.biopsych.2006.05.040.CrossRefPubMedGoogle Scholar
- 11.Torres AR, Fontenelle LF, Shavitt RG, Ferrao YA, do Rosario MC, Storch EA, et al. Comorbidity variation in patients with obsessive-compulsive disorder according to symptom dimensions: results from a large multicentre clinical sample. J Affect Disord. 2016;190:508–16. https://doi.org/10.1016/j.jad.2015.10.051.CrossRefPubMedGoogle Scholar
- 13.Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D, et al. The dimensional Yale-Brown obsessive-compulsive scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry. 2006;11(5):495–504. https://doi.org/10.1038/sj.mp.4001798.CrossRefPubMedGoogle Scholar
- 14.Abramowitz JS, Deacon BJ, Olatunji BO, Wheaton MG, Berman NC, Losardo D, et al. Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the dimensional obsessive-compulsive scale. Psychol Assess. 2010;22(1):180–98. https://doi.org/10.1037/a0018260.CrossRefPubMedGoogle Scholar
- 15.Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006–11. https://doi.org/10.1001/archpsyc.1989.01810110048007.CrossRefPubMedGoogle Scholar
- 19.Fullana MA, Mataix-Cols D, Caspi A, Harrington H, Grisham JR, Moffitt TE, et al. Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatry. 2009;166(3):329–36. https://doi.org/10.1176/appi.ajp.2008.08071006.CrossRefPubMedGoogle Scholar
- 29.Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry. 2001;62(7):535–40. https://doi.org/10.4088/JCP.v62n07a06.CrossRefPubMedGoogle Scholar
- 33.• Williams MT, Farris SG, Turkheimer EN, Franklin ME, Simpson HB, Liebowitz M, et al. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder. J Anxiety Disord. 2014;28(6):553–8. https://doi.org/10.1016/j.janxdis.2014.06.001.The currently highest quality study of how symptom dimensions relate to outcome after CBT, based on data from randomzied controlled trials.CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Buchanan AW, Meng KS, Marks IM. What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder? Anxiety. 1996;2(1):22–7. https://doi.org/10.1002/(SICI)1522-7154(1996)2:1<22::AID-ANXI3>3.0.CO;2-F.CrossRefPubMedGoogle Scholar
- 38.Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156(9):1409–16. https://doi.org/10.1176/ajp.156.9.1409.PubMedGoogle Scholar
- 46.• Bruce SL, Ching THW, Williams MT. Pedophilia-themed obsessive-compulsive disorder: assessment, differential diagnosis, and treatment with exposure and response prevention. Arch Sex Behav. 2017. Recent and excellent overview of pedophelia-related fears in OCD, including suggestions for addressing these in treatment.Google Scholar
- 51.Thorsen AL, Hagland P, Radua J, Mataix-Cols D, Kvale G, Hansen B, et al. Emotional processing in obsessive-compulsive disorder: a systematic review and meta-analysis of 25 functional neuroimaging studies. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. https://doi.org/10.1016/j.bpsc.2018.01.009
- 52.Anticevic A, Hu S, Zhang S, Savic A, Billingslea E, Wasylink S, et al. Global resting-state fMRI analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biol Psychiatry. 2014;75(8):595–605. https://doi.org/10.1016/j.biopsych.2013.10.021.CrossRefPubMedGoogle Scholar
- 55.• Boedhoe PSW, Schmaal L, Abe Y, Alonso P, Ameis SH, Anticevic A, et al. Cortical abnormalities associated with pediatric and adult obsessive-compulsive disorder: Findings from the ENIGMA Obsessive-Compulsive Disorder working group. Am J Psychiatry. 2017;1–21. A comprehensive mega-analysis of subcortical structural alterations in OCD, which includes a large analysis of the relation symptom dimensions and subcortical volume.Google Scholar
- 56.Alvarenga PG, do Rosario MC, Batistuzzo MC, Diniz JB, Shavitt RG, Duran FL, et al. Obsessive-compulsive symptom dimensions correlate to specific gray matter volumes in treatment-naive patients. J Psychiatr Res. 2012;46(12):1635–42. https://doi.org/10.1016/j.jpsychires.2012.09.002.
- 57.Hirose M, Hirano Y, Nemoto K, Sutoh C, Asano K, Miyata H, et al. Relationship between symptom dimensions and brain morphology in obsessive-compulsive disorder. Brain Imaging Behav. 2016;1–8.Google Scholar
- 59.Okada K, Nakao T, Sanematsu H, Murayama K, Honda S, Tomita M, et al. Biological heterogeneity of obsessive-compulsive disorder: a voxel-based morphometric study based on dimensional assessment. Psychiatry Clin Neurosci. 2015;69(7):411–21. https://doi.org/10.1111/pcn.12269.CrossRefPubMedGoogle Scholar
- 65.Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004;61(6):564–76. https://doi.org/10.1001/archpsyc.61.6.564.CrossRefPubMedGoogle Scholar
- 67.Phillips M, Marks I, Senior C, Lythgoe D, O'DWYER A-M, Meehan O, et al. A differential neural response in obsessive–compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med. 2000;30(5):1037–50. https://doi.org/10.1017/S0033291799002652.CrossRefPubMedGoogle Scholar
- 68.Marsh R, Horga G, Parashar N, Wang Z, Peterson BS, Simpson HB. Altered activation in fronto-striatal circuits during sequential processing of conflict in unmedicated adults with obsessive-compulsive disorder. Biol Psychiatry. 2014;75(8):615–22. https://doi.org/10.1016/j.biopsych.2013.02.004.CrossRefPubMedGoogle Scholar
- 74.Harrison BJ, Pujol J, Soriano-Mas C, Hernández-Ribas R, López-Solà M, Ortiz H, et al. Neural correlates of moral sensitivity in obsessive-compulsive disorder. Arch Gen Psychiatry. 2012;69(7):741–9. https://doi.org/10.1001/archgenpsychiatry.2011.2165.CrossRefPubMedGoogle Scholar
- 77.Olatunji BO, Ferreira-Garcia R, Caseras X, Fullana MA, Wooderson S, Speckens A, et al. Predicting response to cognitive behavioral therapy in contamination-based obsessive-compulsive disorder from functional magnetic resonance imaging. Psychol Med. 2013:1–13.Google Scholar
- 82.Olatunji BO, Abramowitz JS, Williams NL, Connolly KM, Lohr JM. Scrupulosity and obsessive-compulsive symptoms: confirmatory factor analysis and validity of the Penn inventory of scrupulosity. J Anxiety Disord. 2007;21(6):771–87. https://doi.org/10.1016/j.janxdis.2006.12.002.CrossRefPubMedGoogle Scholar
- 91.Kircanski K, Mortazavi A, Castriotta N, Baker AS, Mystkowski JL, Yi R, et al. Challenges to the traditional exposure paradigm: variability in exposure therapy for contamination fears. J Behav Ther Exp Psychiatry. 2012;43(2):745–51. https://doi.org/10.1016/j.jbtep.2011.10.010.CrossRefPubMedGoogle Scholar
- 93.Schmaal L, Marquand AF, Rhebergen D, van Tol M-J, Ruhé HG, van der Wee NJA, et al. Predicting the naturalistic course of major depressive disorder using clinical and multimodal neuroimaging information: a multivariate pattern recognition study. Biol Psychiatry. 2015;78(4):278–86. https://doi.org/10.1016/j.biopsych.2014.11.018.CrossRefPubMedPubMedCentralGoogle Scholar
- 95.Lenhard F, Sauer S, Andersson E, Mansson KN, Mataix-Cols D, Ruck C, et al. Prediction of outcome in internet-delivered cognitive behaviour therapy for paediatric obsessive-compulsive disorder: a machine learning approach. Int J Methods Psychiatr Res. 2017;Google Scholar